Epithelial Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy: Stratification of Survival With CT-Derived Tumor Volume

被引:74
作者
Gill, Ritu R. [1 ]
Richards, William G. [2 ]
Yeap, Beow Y. [3 ]
Matsuoka, Shin [1 ]
Wolf, Andrea S. [2 ]
Gerbaudo, Victor H. [1 ]
Bueno, Raphael [2 ]
Sugarbaker, David J. [2 ]
Hatabu, Hiroto [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Thorac Surg, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
关键词
CT; imaging biomarkers; mesothelioma; pleura; pneumonectomy; survival; tumor volume; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; TRIMODALITY THERAPY; PROGNOSTIC-FACTORS; PREDICTION; EXPERIENCE; DISEASE; CANCER;
D O I
10.2214/AJR.11.7015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to assess the usefulness of CT-derived tumor volume, with control for other prognostic factors, for stratifying survival after surgery-based multimodality treatment of a large cohort of patients with epithelial malignant pleural mesothelioma. MATERIALS AND METHODS. We retrospectively reviewed 338 patients with mesothelioma who underwent extrapleural pneumonectomy between 2001 and 2007. The study cohort comprised 88 patients with epithelial subtype tumors, DICOM-format CT scans, and data regarding neoadjuvant and adjuvant therapy. Tumor volume was calculated, and Kaplan-Meier survival and Cox regression analyses were performed to compare the estimated survival functions of patient subgroups based on volume and other covariates related to outcome (sex, age, preoperative platelet count, hemoglobin concentration, WBC count, clinical and pathologic TNM category, and administration of neoadjuvant and adjuvant therapy). A multivariate regression model was derived on the basis of the most significant univariate predictors. RESULTS. The median estimated tumor volume was 319 cm(3) (range, 4-3256 cm(3)). In univariate analysis, tumor volume, hemoglobin concentration, platelet count, pathologic TNM category, and administration of adjuvant chemotherapy or radiation therapy met the criteria for inclusion in the reverse stepwise regression analysis. In the final model, tumor volume, hemoglobin concentration, and administration of adjuvant chemotherapy or radiotherapy were identified as independently associated with overall survival. CONCLUSION. With control of prognostic covariates, CT-derived tumor volume can be used to stratify survival of patients with epithelial mesothelioma after extrapleural pneumonectomy and should be included in prognostic evaluation of patients for whom resection is being considered.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 1968, World Health Organization Technical Report Series, V405, P5
[2]  
Chen X, 2005, C P IEEE ENG MED BIO, V1, P562
[3]   Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience [J].
Curran, D ;
Sahmoud, T ;
Therasse, P ;
van Meerbeeck, J ;
Postmus, PE ;
Giaccone, G .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :145-152
[4]   Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems [J].
Edwards, JG ;
Abrams, KR ;
Leverment, JN ;
Spyt, TJ ;
Waller, DA ;
O'Byrne, KJ .
THORAX, 2000, 55 (09) :731-735
[5]   Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience [J].
Flores, RM .
LUNG CANCER, 2005, 49 :S71-S74
[6]   Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma [J].
Flores, RM ;
Akhurst, T ;
Gonen, M ;
Larson, SM ;
Rusch, VW .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (01) :11-16
[7]   Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma [J].
Gordon, Gavin J. ;
Dong, Lingsheng ;
Yeap, Beow Y. ;
Richards, William G. ;
Glickman, Jonathan N. ;
Edenfield, Heather ;
Mani, Madhubalan ;
Colquitt, Richard ;
Maulik, Gautam ;
Van Oss, Branden ;
Sugarbaker, David J. ;
Bueno, Raphael .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (09) :678-686
[8]   Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging [J].
Heelan, RT ;
Rusch, VW ;
Begg, CB ;
Panicek, DM ;
Caravelli, JF ;
Eisen, C .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (04) :1039-1047
[9]   Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J].
Herndon, JE ;
Green, MR ;
Chahinian, AP ;
Corson, JM ;
Suzuki, Y ;
Vogelzang, NJ .
CHEST, 1998, 113 (03) :723-731
[10]   Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications [J].
Lee, Ho Yun ;
Hyun, Seung Hyup ;
Lee, Kyung Soo ;
Kim, Byung-Tae ;
Kim, Jhingook ;
Shim, Young Mog ;
Ahn, Myung-Ju ;
Kim, Tae Sung ;
Yi, Chin A. ;
Chung, Myung Jin .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (10) :2787-2794